... of the biopharmaceutical company's stock worth $980,000 after buying an additional 4,588 shares during the period. Ardsley Advisory Partners boosted its stake in shares of Abeona Therapeutics by 33.3% during the second quarter. Ardsley Advisory ...
http://ift.tt/2z1lW58
No comments:
Post a Comment